vitamin K2 MK-7 high dose
Selected indexed studies
- Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. (Osteoporos Int, 2013) [PMID:23525894]
- Vitamin K(2)-MK-7 improves nitric oxide-dependent endothelial function in ApoE/LDLR(-/-) mice. (Vascul Pharmacol, 2019) [PMID:31421222]
- Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study. (Nephrol Dial Transplant, 2014) [PMID:24285428]
_Worker-drafted node — pending editorial review._
Connections
vitamin K2 MK-7 high dose helps
vitamin K2 MK-7 high dose protects against
Sources
- Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. (2013) pubmed
- The antiosteoporotic effects of Cheonggukjang containing vitamin k2 (menaquinone-7) in ovariectomized rats. (2014) pubmed
- Vitamin K(2)-MK-7 improves nitric oxide-dependent endothelial function in ApoE/LDLR(-/-) mice. (2019) pubmed
- Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study. (2014) pubmed
- High-Dose Menaquinone-7 Supplementation Reduces Cardiovascular Calcification in a Murine Model of Extraosseous Calcification. (2015) pubmed
- Vitamin K2 Supplementation in Hospitalised COVID-19 Patients: A Randomised Controlled Trial. (2024) pubmed
- Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects. (2012) pubmed
- Menaquinone-7 ameliorates cerebrovascular calcification-associated memory decline in aged mice. (2022) pubmed
- Menaquinone-7 Supplementation Increases Multiple Advanced Glycation End-Products and Oxidation Markers in Zucker Diabetic Fatty Rats. (2025) pubmed
- Short-term impact of vitamin K2 supplementation on biochemical parameters and lipoprotein fractions. (2025) pubmed